Slide 1: Q2 Investor Presentation
Q2 Investor Presentation August 2025
Slide 2: Disclosures
Disclosures Forward-Looking Statements This presentation may contain "forward-looking statements," which include information concerning Celanese Corporation’s (the “Company”) plans objectives, goals, strategies, future revenues, cash flow, financial performance, synergies, capital expenditures, dele
Slide 3: Discussion Topics
Discussion Topics Earnings update Key actions and near- term imperatives 3
Slide 4: Q2 2025 Results
Q2 2025 Results Q2 2025 Results Q2 2025 Highlights $311 M $1.44 Improved Engineered Materials (EM) mix due to business actions FREE CASH FLOW* ADJUSTED EPS* Free cash flow* generation focus Weak demand in the Acetyl Chain (AC): ADJUSTED EBIT* BY BUSINESS SEGMENTS • Demand weakness in acetate tow $19
Slide 5: Q3 2025 Outlook
Q3 2025 Outlook Q3 2025 Outlook Q3 2025 Expected Drivers $1.10 – $1.40 Continued emphasis on cost reduction Q3 ADJUSTED EPS* GUIDANCE initiatives across both businesses Sequential improvement in AC earnings driven by lower turnaround expense Q3 ADJUSTED EBIT* GUIDANCE BY BUSINESS SEGMENTS Actions to
Slide 6: Actions expected to deliver $120M cost savings in 2025, with future incremental opportunities of $50M - $100M
Actions expected to deliver $120M cost savings in 2025, with future incremental opportunities of $50M - $100M Cost Reduction Initiatives Cost Reduction Realization Targets by Year ($M) Near Term Cost $80 - $90 million Reductions of targeted annualized savings $80 $10 primarily through headcount redu
Slide 7: Key actions expected to deliver higher YoY Free Cash Flow despite lower demand environment
Key actions expected to deliver higher YoY Free Cash Flow* despite lower demand environment FY 2025 Targeted Free Cash Flow* ($M) $800 M $700 M Strong free cash flow* performance ~40% - ~60 % $311 million in Q2 2025 $498 M 1H 2025 free cash flow* is higher YOY by ~80% $238 M $105 M On track to achie
Slide 8: Celanese action plans and strong business fundamentals driving management of near-term uncertainty
Celanese action plans and strong business fundamentals driving management of near-term uncertainty Acetyl Chain → Drive productivity through low cost, U.S. based assets → Leverage strength of the underlying operating model → Maximize sales opportunities in downstream products INCREASE CASH INTENSIFY
Slide 9: The Acetyl Chain offers multiple highly differentiated, long-term value creation levers
The Acetyl Chain offers multiple highly differentiated, long-term value creation levers AC Operating EBITDA* margin has consistently been greater than 20% for the past five years Global leader in attractive growth markets Chain Legacy Business Enhanced Flexibility Implementation 2500 COVID 40% recov
Slide 10: Global Acetyls leader with an integrated value chain
Global Acetyls leader with an integrated value chain Leverage unique integrated global product chain and advantaged cost position to predict and adapt to global dynamics and trends 1 2 4 5 6 Carbon Acetic Acid VAM Emulsions Powders Monoxide Significant Advantages with Chain Optionality 1 Anhydride &
Slide 11: AC western hemisphere presence in acetic acid and VAM helps minimize further impacts of industry over-supply in China
AC western hemisphere presence in acetic acid and VAM helps minimize further impacts of industry over-supply in China Asia drives recent AC declines in revenue and Overcapacity in China remains largely in Asia; corresponding declines in earnings, while western CE U.S. based production into Europe co
Slide 12: The stability of the western hemisphere business is supported by contractual positions
The stability of the western hemisphere business is supported by contractual positions AC revenue – and margins – generated from the western hemisphere have been consistent, and largely under contract → Industry leading reliability Average Percent of AC Revenue Derived from WH Percent of AC WH Reven
Slide 13: Acetyl Chain model is well positioned to drive downstream growth
Acetyl Chain model is well positioned to drive downstream growth Continued evolution towards downstream derivatives amplifies chain optionality and increases sales from high value downstream applications → Prior investments in capacity and 2019 2020 2021 2022 2023 2024 acquisitions position AC for E
Slide 14: EM offers an industry leading portfolio of polymer solutions
EM offers an industry leading portfolio of polymer solutions LCP Vectra® | Zenite® Performance Broad Polymer Portfolio Polymers PPS Fortron® High PPA Frianyl® XT | Celanyl® XT | Zytel® 25-30 Universe of Engineered Polymers PCT Thermx® LCPA Zytel® ~19 Celanese Engineered Materials PA 66 Frianyl® | Ce
Slide 15: High Impact Programs (HIPs) drive EM growth
High Impact Programs (HIPs) drive EM growth EM earnings stabilizing in a low demand environment… High Impact Programs (HIPs): high performance, demanding projects that drive higher margin EM Adjusted EBIT* ($M) Q3 Top four High Impact Program segments $214 sequential $170- inventory $144 $190 reduct
Slide 16: EM working capital reduction contributes to free cash flow in 2025 with further opportunities in 2026+
EM working capital reduction contributes to free cash flow* in 2025 with further opportunities in 2026+ 2.3 0.4 On track to achieve 2.1 $100 million inventory reduction goal 0.35 1.9 in 2025 31% Strong focus on inventory reduction, 1.7 29% 0.3 leveraging multiple drivers while 30% maintaining supply
Slide 17: Resilient businesses are generating cash, aligning debt maturities with cash flow generation capabilities
Resilient businesses are generating cash, aligning debt maturities with cash flow generation capabilities Debt Maturity Profile1 Strong execution against Targeting to address maturities through 2027 with free cash flow* deleveraging plans and divestiture proceeds → $200 M delayed-draw term fully pai
Slide 18: Relentless focus on additional actions to drive earnings towards $2 adjusted earnings per share
Relentless focus on additional actions to drive earnings towards $2 adjusted earnings per share* Quarterly Adjusted EPS* $50 to $100 million additional cost reductions ~ $2.00 → Further footprint optimization across manufacturing and distribution network $1.44 $1.10 to $1.40 → Functional cost reduct
Slide 19: Celanese Offers a Compelling Investment Opportunity
Celanese Offers a Compelling Investment Opportunity Our mission is to position Celanese Leadership driving Actions underway to Strong earnings as a top quartile change deliver near-term leverage as demand company for total earnings improvement recovers shareholder return by delivering earnings growt
Slide 20: Upcoming Investor Relations Events
Upcoming Investor Relations Events Aug 13 Mizuho Industrials Conference, New York Sept 3 UBS Global Materials Conference, New York Sept 9 Alembic Global, Torrey Pines Sept 10 Morgan Stanley Conference, Laguna Beach Sept 16 RBC Conference, New York 20